Bleeding disorder trial halted after pomalidomide drug proves efficacy
Researchers supported by the National Institutes of Health stopped a trial after they gathered sufficient evidence that an experimental drug to treat a.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Researchers supported by the National Institutes of Health stopped a trial after they gathered sufficient evidence that an experimental drug to treat a.
Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and.
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer.
HQ Team April 25, 2024: The US health regulator has approved a drug of Utility Therapeutics to treat adult women, 18 years or.
HQ Team April 20, 2024: A bacteria that causes infections, including pneumonia, bloodstream infections, and meningitis are being treated by doctors with less.
HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study.
HQ Team March 18, 2024: A gene editing technology called CRISPR can help diagnose nontuberculous mycobacteria infections in less than two hours from.
By K. Leelamoni March 18, 2024: Akhila came up with a surprise statement while I was talking to her. “Mam’ I have multiple.
HQ Team March 13, 2024: Cognitive behavioural therapy could be an effective way to reduce the risks of developing postpartum mental health conditions,.
HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.